MUC1: Structure, Function, and Clinic Application in Epithelial Cancers

被引:185
作者
Chen, Wenqing [1 ]
Zhang, Zhu [2 ]
Zhang, Shiqing [2 ]
Zhu, Peili [2 ]
Ko, Joshua Ka-Shun [1 ]
Yung, Ken Kin-Lam [2 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Div Teaching & Res, Hong Kong, Peoples R China
[2] Hong Kong Baptist Univ, Dept Biol, Kowloon Tong, Hong Kong, Peoples R China
关键词
MUC1; epithelial cancer; MUC1 cell barrier; tumor oncogene; therapeutic biomarkers; immunotherapy; PANCREATIC DUCTAL ADENOCARCINOMA; IMMUNOLOGICAL EVALUATION; TRANSMEMBRANE MUCINS; EXTRACELLULAR DOMAIN; IMMUNE EVASION; BREAST-CANCER; DUAL ROLE; GROWTH; ONCOPROTEIN; EXPRESSION;
D O I
10.3390/ijms22126567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transmembrane glycoprotein mucin 1 (MUC1) is a mucin family member that has different functions in normal and cancer cells. Owing to its structural and biochemical properties, MUC1 can act as a lubricant, moisturizer, and physical barrier in normal cells. However, in cancer cells, MUC1 often undergoes aberrant glycosylation and overexpression. It is involved in cancer invasion, metastasis, angiogenesis, and apoptosis by virtue of its participation in intracellular signaling processes and the regulation of related biomolecules. This review introduces the biological structure and different roles of MUC1 in normal and cancer cells and the regulatory mechanisms governing these roles. It also evaluates current research progress and the clinical applications of MUC1 in cancer therapy based on its characteristics.
引用
收藏
页数:15
相关论文
共 110 条
[61]   TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling [J].
Malinda, Raj R. ;
Zeeberg, Katrine ;
Sharku, Patricia C. ;
Ludwig, Mette Q. ;
Pedersen, Lotte B. ;
Christensen, Soren T. ;
Pedersen, Stine F. .
FRONTIERS IN ONCOLOGY, 2020, 10
[62]  
Marczynski M., 2021, Biopolymers for Biomedical and Biotechnological Applications, V181-208, DOI DOI 10.1002/9783527818310.CH6
[63]   Structural Alterations of Mucins Are Associated with Losses in Functionality [J].
Marczynski, Matthias ;
Jiang, Kun ;
Blakeley, Matthew ;
Srivastava, Vaibhav ;
Vilaplana, Francisco ;
Crouzier, Thomas ;
Lieleg, Oliver .
BIOMACROMOLECULES, 2021, 22 (04) :1600-1613
[64]   Membrane-associated mucins of the human ocular surface in health and disease [J].
Martinez-Carrasco, Rafael ;
Argueso, Pablo ;
Fini, M. Elizabeth .
OCULAR SURFACE, 2021, 21 :313-330
[65]   Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides [J].
Martinez-Saez, Nuria ;
Peregrina, Jesus M. ;
Corzana, Francisco .
CHEMICAL SOCIETY REVIEWS, 2017, 46 (23) :7154-7175
[66]   Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems [J].
Maupin, Kevin A. ;
Sinha, Arkadeep ;
Eugster, Emily ;
Miller, Jeremy ;
Ross, Julianna ;
Paulino, Vincent ;
Keshamouni, Venkateshwar G. ;
Tran, Nhan ;
Berens, Michael ;
Webb, Craig ;
Haab, Brian B. .
PLOS ONE, 2010, 5 (09)
[67]   Synthesis of a Self-Adjuvanting MUC1 Vaccine via Diselenide-Selenoester Ligation-Deselenization [J].
McDonald, David M. ;
Hanna, Cameron C. ;
Ashhurst, Anneliese S. ;
Corcilius, Leo ;
Byrne, Scott N. ;
Payne, Richard J. .
ACS CHEMICAL BIOLOGY, 2018, 13 (12) :3279-3285
[68]   Anti-MUC1 aptamer: A potential opportunity for cancer treatment [J].
Nabavinia, Maryam Sadat ;
Gholoobi, Aida ;
Charbgoo, Fahimeh ;
Nabavinia, Mahboobeh ;
Ramezani, Mohammad ;
Abnous, Khalil .
MEDICINAL RESEARCH REVIEWS, 2017, 37 (06) :1518-1539
[69]   Dendritic Cell-based Immunotherapy Pulsed With Wilms Tumor 1 Peptide and Mucin 1 as an Adjuvant Therapy for Pancreatic Ductal Adenocarcinoma After Curative Resection: A Phase I/IIa Clinical Trial [J].
Nagai, Kazuhiro ;
Adachi, Tomohiko ;
Harada, Hiroshi ;
Eguchi, Susumu ;
Sugiyama, Haruo ;
Miyazaki, Yasushi .
ANTICANCER RESEARCH, 2020, 40 (10) :5765-5776
[70]   MUC1: a multifaceted oncoprotein with a key role in cancer progression [J].
Nath, Sritama ;
Mukherjee, Pinku .
TRENDS IN MOLECULAR MEDICINE, 2014, 20 (06) :332-342